XJPX
3341
Market cap719mUSD
Dec 18, Last price
3,910.00JPY
Name
Nihon Chouzai Co Ltd
Chart & Performance
P/E
83.98
P/S
0.32
EPS
46.56
Div Yield, %
0.64%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
6.07%
Revenues
360.51b
+5.94%
Net income
1.39b
-45.52%
CFO
8.82b
-56.79%
Dividend
Sep 29, 202512.5 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nihon Chouzai Co., Ltd. is a Japanese enterprise primarily known for operating a vast network of health insurance-compliant dispensing pharmacies throughout the country. Beyond its core retail pharmacy business, the company develops and markets generic medications, supplying them to various medical facilities and other drug retailers. It also provides diverse human resources solutions, including temporary staffing for pharmacists and recruitment services for medical doctors, licensed sales personnel, and other professionals within the healthcare industry. Additionally, Nihon Chouzai offers specialized research and study services to pharmaceutical companies and related organizations, alongside providing expert information and consulting to the broader pharmaceutical and healthcare sectors. A range of other services are also part of its portfolio. As of March 31, 2022, the company operated 697 stores. Established in 1980, its corporate headquarters are located in Tokyo, Japan.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||